Pharmacy Podcast Episode 101: Long Acting Lipoglycopeptides: Antibiotic Friend or Foe?
Pharmacy Grand Rounds Podcast |
Speaker: Andrew J. Jatis, PharmD,
Twitter: @jatis_rx
Andrew J. Jatis, PharmD, (@jatis_rx) reviews the pharmacology and drug characteristics of dalbavancin and oritavancin, describes current literature assessing the safety and efficacy of FDA approved and off-label indications for lipoglycopeptide use in clinical practice and discusses pharmacoeconomic implications of lipoglycopeptide use in clinical practice.
Learning Objectives
- Review the pharmacology and drug characteristics of dalbavancin and oritavancin.
- Describe current literature assessing the safety and efficacy of FDA approved and off-label indications for lipoglycopeptide use in clinical practice.
- Discuss pharmacoeconomic implications of lipoglycopeptide use in clinical practice.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 0.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
ACPE
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 0.50 ACPE Knowledge -based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity.
ACPE UAN Number: JA0000238-0000-22-054-H01-P
AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. Approval is valid until 12/31/2024. This activity is designated for 0.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.
Available Credit
- 0.50 AAPA Category 1
- 0.50 ACPE
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Attendance
Price
Registration required to claim CME credit.
Click here to view the online course Cancellation and Refund Policy.
Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.